MetaCap

Protalix BioTherapeutics (DE) (PLX) News

NYSE: PLXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.90-0.16 (-5.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PLX news summary

We found 6 recent headlines mentioning Protalix BioTherapeutics (DE) (PLX): 0 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq, PR Newswire. PLX is making an outsized move today, down 5.23% at $2.90, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Protalix BioTherapeutics Inc. Q3 Income Advances", was published by Nasdaq on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Protalix BioTherapeutics (DE) headlines

Compare PLX